AMACR
AMACR (alpha-methylacyl-CoA racemase, also known as RACE and P504S) is a racemase that interconverts the (R)- and (S)-stereoisomers of alpha-methyl-branched-chain fatty acyl-CoA esters. It is found in both peroxisomes and mitochondria. Browse Assay Genie's current range of AMACR research reagents below, or read on for the biology behind the target.
AMACR catalyses the interconversion of (R)- and (S)-stereoisomers of alpha-methyl-branched-chain fatty acyl-CoA esters. It acts only on coenzyme A thioesters, not on free fatty acids, and accepts a wide range of alpha-methylacyl-CoAs as substrates. These include pristanoyl-CoA, trihydroxycoprostanoyl-CoA (an intermediate in bile acid synthesis) and arylpropionic acids such as the anti-inflammatory drug ibuprofen. It does not act on 3-methyl-branched or linear-chain acyl-CoAs.
The reaction has a clear physiological purpose. According to the NCBI Gene summary, the enzyme interconverts pristanoyl-CoA and C27-bile acyl-CoAs between their (R)- and (S)-forms, and conversion to the (S)-stereoisomers is necessary for these substrates to be degraded by peroxisomal beta-oxidation. The protein localises to both mitochondria and peroxisomes. It belongs to the CoA-transferase III family and is classified as EC 5.1.99.4.
The AMACR gene is also known by the aliases RACE and P504S, and has mouse and rat orthologs, both named Amacr. Mutations in the gene may be associated with adult-onset sensorimotor neuropathy, pigmentary retinopathy, and adrenomyeloneuropathy arising from defects in bile acid synthesis. Alternatively spliced transcript variants have been described. Read-through transcription also occurs between this gene and the neighbouring upstream gene C1QTNF3 (C1q and tumour necrosis factor related protein 3).
AMACR supplies the (S)-stereoisomers of pristanoyl-CoA that peroxisomal beta-oxidation requires, making it a key enzyme for studying branched-chain fatty acid degradation.
The enzyme converts C27-bile acyl-CoAs, including trihydroxycoprostanoyl-CoA, between stereoisomers, linking it to the study of bile acid biosynthesis defects.
Mutations in the gene may be associated with sensorimotor neuropathy, pigmentary retinopathy and adrenomyeloneuropathy, so AMACR is relevant to inherited metabolic disease research.
AMACR accepts arylpropionic acids such as ibuprofen as substrates, which makes it relevant to research on the stereochemistry of profen drug metabolism.
AMACR is a racemase that interconverts the (R)- and (S)-stereoisomers of alpha-methyl-branched-chain fatty acyl-CoA esters, such as pristanoyl-CoA and C27-bile acyl-CoAs. Conversion to the (S)-form is needed for degradation by peroxisomal beta-oxidation. It acts only on CoA thioesters, not free fatty acids.
AMACR stands for alpha-methylacyl-CoA racemase. It is also known by the aliases RACE and P504S. The enzyme is classified as EC 5.1.99.4 and belongs to the CoA-transferase III family. Alternatively spliced transcript variants of the gene have been described.
Mouse and rat both have an ortholog named Amacr, so rodent systems can be used to study the gene; check the datasheet of any product for its validated reactivity. In humans, mutations may be associated with adult-onset sensorimotor neuropathy, pigmentary retinopathy and adrenomyeloneuropathy due to defects in bile acid synthesis.
Neighbouring genes and other peroxisomal and bile acid metabolism targets with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q9UHK6; product specifications from Assay Genie datasheets.